BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8508383)

  • 1. Immunoscintigraphy in primary colorectal cancer.
    Ryan JW
    Cancer; 1993 Jun; 71(12 Suppl):4217-24. PubMed ID: 8508383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoscintigraphy in patients with colorectal, ovarian, and prostate cancer. Results with site-specific immunoconjugates.
    Maguire RT; Pascucci VL; Maroli AN; Gulfo JV
    Cancer; 1993 Dec; 72(11 Suppl):3453-62. PubMed ID: 8242578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-111 CYT-103 monoclonal antibody imaging in patients with suspected recurrent colorectal cancer.
    Doerr RJ; Herrera L; Abdel-Nabi H
    Cancer; 1993 Jun; 71(12 Suppl):4241-7. PubMed ID: 8508386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CEA-immunoscintigraphy with 99m-technetium correlates with tumour cell differentiation in colorectal cancer.
    Wittig BM; Hach A; Hahn K; Meyer zum Büschenfelde KH; Dippold WG
    Eur J Cancer; 1993; 29A(9):1327-9. PubMed ID: 8343279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoscintigraphy of colorectal cancer using 111In-labeled monoclonal antibody to mucin.
    Sakahara H; Onodera H; Shirato M; Yao Z; Ohshio G; Kobayashi H; Hosono M; Yano S; Nakada H; Imamura M
    Cancer Immunol Immunother; 1995 Sep; 41(3):157-61. PubMed ID: 7553684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer. Radiologic staging.
    Thoeni RF
    Radiol Clin North Am; 1997 Mar; 35(2):457-85. PubMed ID: 9087214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative detection of occult colon cancer micrometastases using 125 I-radiolabled monoclonal antibody CC49.
    Cote RJ; Houchens DP; Hitchcock CL; Saad AD; Nines RG; Greenson JK; Schneebaum S; Arnold MW; Martin EW
    Cancer; 1996 Feb; 77(4):613-20. PubMed ID: 8616751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-carcinoembryonic antigen immunoscintigraphy (technetium-99m-monoclonal antibody BW 431/26) and serum CEA levels in patients with suspected primary and recurrent colorectal carcinoma.
    Lind P; Lechner P; Arian-Schad K; Klimpfinger M; Cesnik H; Kammerhuber F; Eber O
    J Nucl Med; 1991 Jul; 32(7):1319-25. PubMed ID: 2066784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pitfalls in antibody imaging in colorectal cancer.
    Tempero M
    Cancer; 1993 Jun; 71(12 Suppl):4248-51. PubMed ID: 8508387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indium 111 ZCE-025 immunoscintigraphy in occult recurrent colorectal cancer with elevated carcinoembryonic antigen level.
    Doerr RJ; Abdel-Nabi H; Merchant B
    Arch Surg; 1990 Feb; 125(2):226-9. PubMed ID: 2302062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative imaging of colorectal cancers. Targeting the epithelial membrane antigen with a radiation-labeled monoclonal antibody.
    Davidson BR; Young H; Waddington WA; Babich J; Clarke GA; Short MD; Boulos PB; Styles J; Dean C; Ell PJ
    Cancer; 1992 Feb; 69(3):620-5. PubMed ID: 1730114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. The Immunomedics Study Group.
    Moffat FL; Pinsky CM; Hammershaimb L; Petrelli NJ; Patt YZ; Whaley FS; Goldenberg DM
    J Clin Oncol; 1996 Aug; 14(8):2295-305. PubMed ID: 8708720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoscintigraphy performed with In-111-labeled CYT-103 in the management of colorectal cancer: comparison with CT.
    Collier BD; Abdel-Nabi H; Doerr RJ; Harwood SJ; Olsen J; Kaplan EH; Winzelberg GG; Grossman SJ; Krag DN; Mitchell EP
    Radiology; 1992 Oct; 185(1):179-86. PubMed ID: 1523304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value of immunoscintigraphy in the rectal carcinomas: immunoscintigraphy of rectal carcinomas.
    Petrovic M; Jankovic Z; Jaukovic Lj; Artiko V; Šobic-Šaranovic D; Antic A; Žuvela M; Radovanovic N; Palibrk I; Galun D; Matic S; Loncar Z; Bojovic P; Ajdinovic B; Obradovic V
    Hepatogastroenterology; 2013 Sep; 60(126):1355-9. PubMed ID: 23340231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CEA immunoscintigraphy might be more useful than computed tomography in the preoperative thoracic evaluation of lung cancer. A comparison between planar immunoscintigraphy, single photon emission computed tomography (SPECT), and computed tomography.
    Buccheri G; Biggi A; Ferrigno D; Leone A; Taviani M; Quaranta M
    Chest; 1993 Sep; 104(3):734-42. PubMed ID: 8365283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoscintigraphy of primary colorectal cancers with indium-111 monoclonal antibody B72.3.
    Joypaul BV; Kennedy N; Hanson J; Holley M; Browning M; Newman EL; Cuschieri A
    J R Coll Surg Edinb; 1994 Feb; 39(1):39-43. PubMed ID: 7515429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New methods for the staging of colorectal cancer using noninvasive techniques.
    Blend MJ; Abdel-Nabi H
    Semin Surg Oncol; 1996; 12(4):253-63. PubMed ID: 8829284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of immunoscintigraphy in the follow-up of surgically treated gastrointestinal carcinomas using 111In-labelled anti-CEA monoclonal antibodies.
    Cimitan M; Boz G; Spaziante R; Sorce P; De Paoli A; Baldoncini A; Borsatti E; Trovò MG; Zecchin R
    Clin Oncol (R Coll Radiol); 1992 Nov; 4(6):368-72. PubMed ID: 1463689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of clinical staging algorithms and 111indium-capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients.
    Polascik TJ; Manyak MJ; Haseman MK; Gurganus RT; Rogers B; Maguire RT; Partin AW
    Cancer; 1999 Apr; 85(7):1586-92. PubMed ID: 10193950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunodetection of solid tumors. Future horizons and applications for radioimmunotherapy.
    McKearn TJ
    Cancer; 1993 Jun; 71(12 Suppl):4302-13. PubMed ID: 8508392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.